These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11966505)

  • 1. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study.
    Hallerbäck BI; Bommelaer G; Bredberg E; Campbell M; Hellblom M; Lauritsen K; Wienbeck M; Holmgren LL
    Aliment Pharmacol Ther; 2002 May; 16(5):959-67. PubMed ID: 11966505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
    Amarapurkar DN; Rane P
    J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
    Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of postprandial discomfort syndrome in the elderly: a multi-centered prospective randomized controlled clinical study].
    Wang GS; Xu L; Chen HT; Shi LP; Huang MJ; Xi L; Xu LS; Wang F; Li HY; Li S; Zhang YJ; Tan SY; Hong RT; Lyu NH; Ye M; Gan HT; Liu M; Wu BY;
    Zhonghua Nei Ke Za Zhi; 2020 Feb; 59(2):117-123. PubMed ID: 32074684
    [No Abstract]   [Full Text] [Related]  

  • 5. Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS).
    Hongo M; Harasawa S; Mine T; Sasaki I; Matsueda K; Kusano M; Hanyu N; Nakada K; Shibata C
    J Gastroenterol Hepatol; 2012 Jan; 27(1):62-8. PubMed ID: 22004457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosapride in gastrointestinal disorders.
    Curran MP; Robinson DM
    Drugs; 2008; 68(7):981-91. PubMed ID: 18457463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial.
    Yoon H; Lee DH; Lee YH; Jeong JC; Lee ST; Choi MG; Jeon SW; Shim KN; Baik GH; Kim JG; Moon JS; Sung IK; Lee SK; Rhee PL; Jung HY; Lee BE; Kim HS; Kim SG; Lee KM; Seong JK; Jang JS; Park JJ
    Gut Liver; 2018 Sep; 12(5):516-522. PubMed ID: 29938452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of mosapride on quality of life in functional dyspepsia].
    Cho YK; Choi MG; Kim SH; Lee IS; Kim SW; Chung IS; Lee SY; Choi SC; Seol SY
    Korean J Gastroenterol; 2004 Mar; 43(3):160-7. PubMed ID: 15034286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosapride treatment for functional dyspepsia: a meta-analysis.
    Bang CS; Kim JH; Baik GH; Kim HS; Park SH; Kim EJ; Kim JB; Suk KT; Yoon JH; Kim YS; Kim DJ
    J Gastroenterol Hepatol; 2015 Jan; 30(1):28-42. PubMed ID: 25041564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
    Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease.
    Ruth M; Hamelin B; Röhss K; Lundell L
    Aliment Pharmacol Ther; 1998 Jan; 12(1):35-40. PubMed ID: 9692698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies.
    Seno H; Nakase H; Chiba T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
    Yang YJ; Bang CS; Baik GH; Park TY; Shin SP; Suk KT; Kim DJ
    BMC Gastroenterol; 2017 Jun; 17(1):83. PubMed ID: 28651565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
    Sun J; Yuan YZ; Holtmann G
    Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis.
    Hsu YC; Yang TH; Hsu WL; Wu HT; Cheng YC; Chiang MF; Wang CS; Lin HJ
    Br J Clin Pharmacol; 2010 Aug; 70(2):171-9. PubMed ID: 20653670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.